Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic

Oncology Patients Clinical Trial

Official title:

An Observational Study to Identify the Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic and the Resulting Lockdown

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04406844
• Other study ID #: Onco_Covid-19
• Status: Recruiting
• Start date: May 9, 2020
• Est. completion date: June 30, 2021

Study information

• Verified date: July 2020
• Source: Max Healthcare Insititute Limited
• Contact: Rajesh Saxena
• Phone: 9818474003
• Email: rajesh.saxena[@]maxhealthcare.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

In view of increasing cases of SARS-CoV-2 leading to the COVID-19 Pandemic in India,there has been unprecedented restrictions on travel, work and other aspects of daily life. Our study has been designed to collect data of cancer patients to analyze their issues and challenges during Covid-19 Pandemic.

Description:

Protocol No: Onco_Covid-19

Version no:1.0

Objectives: Firstly the patients recently diagnosed with cancer will be selected for enrollment who are on active treatment during lockdown based on the date of their registration in the hospital. This is followed by a telephonic interview with patients or their attendant to carry out a prospective, cross-sectional, observational study in order to address the issues and challenges faced by them during Lockdown.

Collection of data will be done through telephonic communication. Participation in this study will be entirely voluntary. Telephonic verbal consent will be taken from the patients or their attendants before collection of their response on the study questionnaire and then will be asked questions accordingly based on the questionnaire which is available in English and Hindi both. Data and general information regarding participants will only be collected in questionnaire. No personal data of the participants will be taken which will also be conveyed to the participant or attendant during telephonic verbal consent.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 150
• Est. completion date: June 30, 2021
• Est. primary completion date: June 30, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 12 Years to 98 Years

Eligibility

Inclusion Criteria:

• Registered with the Max Institute of Cancer Care between Nov 1st 2019 to Jan 31st 2020

• Were scheduled to receive one or more modalities of treatment (chemotherapy, surgery, radiation therapy, immunotherapy) during the period Feb 1st 2020 to April 30th 2020

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Neoplasms
• Oncology Patients

Locations

Country	Name	City	State
India	Max Superspeciality hospital, A Unit of Balaji Medical and Diagnostic Centre	New Delhi

Sponsors (1)

Lead Sponsor	Collaborator
Max Healthcare Insititute Limited

Country where clinical trial is conducted

India, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Oncology patients	To focus on basic issues encountered by oncology patients such as transportation, medical facility, healthcare support, disease apprehension etc	4-8 weeks